Journal
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume 53, Issue 4, Pages 559-566Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2014-0456
Keywords
community-acquired pneumonia (CAP); C-reactive protein (CRP); CURB-65 score; mortality; procalcitonin; severity of illness; white blood cells
Categories
Funding
- Swiss National Science Foundation [SNSF 3200BO-116177/1, 32003B-135222, PP00P3_150531/1, PP0P3_123346]
- Swiss National Science Foundation (SNF) [32003B_135222] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Background: The added value of biomarkers, such as procalcitonin (PCT), C-reactive protein (CRP), and white blood cells (WBC), as adjuncts to clinical risk scores for predicting the outcome of patients with community-acquired pneumonia (CAP) is in question. We investigated the prognostic accuracy of initial and follow-up levels of inflammatory biomarkers in predicting death and adverse clinical outcomes in a large and well-defined cohort of CAP patients. Methods: We measured PCT, CRP and WBC on days 1, 3, 5, and 7 and followed the patients over 30 days. We applied multivariate regression models and area under the curve (AUC) to investigate associations between these biomarkers, the clinical risk score CURB-65, and clinical outcomes [i.e., death and intensive care unit (ICU) admission]. Results: Of 925 patients with CAP, 50 patients died and 118 patients had an adverse clinical outcome. None of the initial biomarker levels significantly improved the CURB-65 score for mortality prediction. Follow-up biomarker levels showed significant independent association with mortality at days 3, 5, and 7 and with improvements in AUC. Initial PCT and CRP levels were independent prognostic predictors of adverse clinical outcome, and levels of all biomarkers during the course of disease provided additional prognostic information. Conclusions: This study provides robust insights into the added prognostic value of inflammatory markers in CAP. Procalcitonin, CRP, and to a lesser degree WBC provided some prognostic information on CAP outcomes, particularly when considering their kinetics at days 5 and 7 and when looking at adverse clinical outcomes instead of mortality alone.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available